Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin (epinephrine injection, USP)
Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
Failed Dissolution Specifications.
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
Toyota Motor Engineering & Manufacturing (Toyota) is recalling certain 2024-2025 Tacoma 4-wheel drive vehicles. The rear brake hoses can be damaged if mud and dirt builds up inside the rear…
General Motors, LLC (GM) is recalling certain 2022 GMC Sierra 1500 vehicles equipped with chrome front grille deflectors. The attachments that hold the front grille deflectors in place may…
Presence of cathine in product
Ingredient (mustard seeds) tested positive for Salmonella
Possible contamination with Salmonella
Possible contamination with Salmonella
Scheduled process deviation: Final pH of 4.61, 4.66, 4.69, 4.67.
Possible contamination with Salmonella
Possible contamination with Salmonella
Possible contamination with Salmonella
Possible contamination with Salmonella
Potential for Salmonella
Possible contamination with Salmonella
Frozen Peach Mango Sorbet contains undeclared allergen (egg)
Potential contamination with Listeria monocytogenes.
Honda (American Honda Motor Co.) is recalling certain 2025 Honda Pilot vehicles. The third-row passenger seat belt assembly may not function, due to incorrect routing that traps the seat…
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit
Labeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.
Browse recent months with enough recall history for useful comparison.
